Connect with us

Health

Japan cancels a third of contracted Astrazeneca vaccine purchase of 40 mln doses

Japan has cancelled the purchase of about 40 million Astrazeneca Plc COVID-19 vaccine doses it agreed to buy last year, a health ministry official said in parliament on Monday.
The contract allowed the government to cancel a portion of the supply if it was unneeded, the official said in response to lawmakers’ questioning. Japan had originally agreed to buy 120 million of the shots, with the bulk made domestically by Daiichi Sankyo Co. and other local partners.

Read the latest updates in our dedicated coronavirus section.
About Astrazeneca 200,000 doses have been supplied to local governments in Japan, while 63 million doses have donated overseas, the official added.

For the latest headlines, follow our Google News channel online or via the app.
Japan has predominantly relied on the mRNA-type vaccines developed by Pfizer Inc and Moderna Inc for its COVID inoculations and boosters so far.

Read more:

Taiwan orders 700,000 units of Pfizer’s COVID-19 pill as cases rise

Shanghai COVID-19 cases keep rising, food supply problems persist

China labels US concerns over COVID regulations ‘groundless accusations’

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Syria: WHO Regional Director calls for greater investment in health sector

Failure to invest in the health of the Syrian people will only deepen instability in the war-ravaged country and pose threats to regional and global security, a senior official with the World Health Organization (WHO) has said.

Continue Reading

Health

World News in Brief: Vaccine ‘patches’ trial shows promise, lowering catheter infection risk, Guantanamo detainee facing revictimisation

Few enjoy having injections and if you have children, you probably like them even less when it’s time for their mandated vaccine shots.

Continue Reading

Health

No sign yet of H5N1 bird flu spreading between humans, says WHO chief

The H5N1 avian influenza virus has so far shown no signs of adapting to allow human to human transmission, the UN health agency said on Wednesday, urging continued surveillance.

Continue Reading

Trending